Macular dystrophy, vitelliform
A genetic eye disorder affecting the macula
Macular dystrophy, vitelliform | |
---|---|
Synonyms | N/A |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Blurred or distorted vision, central vision loss |
Complications | N/A |
Onset | Childhood or adulthood |
Duration | Progressive |
Types | N/A |
Causes | Genetic mutations |
Risks | N/A |
Diagnosis | Eye examination, genetic testing |
Differential diagnosis | N/A |
Prevention | N/A |
Treatment | Low vision aids, supportive care |
Medication | N/A |
Prognosis | N/A |
Frequency | N/A |
Deaths | N/A |
Macular dystrophy, vitelliform is a rare genetic eye disorder that affects the macula, the central part of the retina responsible for detailed vision. This condition is characterized by the accumulation of yellowish material in the macula, leading to progressive vision loss.
Pathophysiology[edit | edit source]
The condition is caused by mutations in genes responsible for the normal functioning of the retinal pigment epithelium and photoreceptors. The most commonly associated gene is the BEST1 gene, which encodes the protein bestrophin-1. Mutations in this gene disrupt the normal ionic balance in the retinal cells, leading to the accumulation of lipofuscin-like material in the macula.
Clinical Presentation[edit | edit source]
Patients with macular dystrophy, vitelliform typically present with:
- Blurred or distorted vision (metamorphopsia)
- Difficulty reading or recognizing faces
- Central vision loss
The onset of symptoms can vary, with some individuals experiencing symptoms in childhood (juvenile form) and others in adulthood (adult-onset form).
Diagnosis[edit | edit source]
Diagnosis is based on:
- Comprehensive eye examination
- Optical coherence tomography (OCT) to visualize the layers of the retina
- Fluorescein angiography to assess blood flow in the retina
- Genetic testing to identify mutations in the BEST1 gene or other associated genes
Management[edit | edit source]
There is currently no cure for macular dystrophy, vitelliform. Management focuses on:
- Monitoring the progression of the disease
- Providing low vision aids to assist with daily activities
- Genetic counseling for affected individuals and their families
Prognosis[edit | edit source]
The progression of vision loss varies among individuals. Some may maintain relatively good vision for many years, while others may experience significant vision impairment.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD